Featured Firms
Presented by BigVoodoo
The market for all kinds of generic pharmaceutical drugs has been very lucrative for many companies. And now that the manufacture of generic biotech medicines is becoming a legal possibility with the expiration of key patents, generic manufacturers are gearing up to expand from simpler generic pharmaceuticals to so-called biogenerics, also known as follow-on biologics.
June 20, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Legal Times
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS